New Zealand drug company AFT Pharmaceuticals has gained regulatory approval for its liquid pain relief developed for children, in Europe, and hopes to eventually get United States approval. “There’s often a concern around the world that a lot of medicines aren’t available in children’s versions, and then on the other hand they actually are quite challenging to develop,” said AFT Pharmaceuticals chief executive Hartley Atkinson​ on Wednesday. AFT had children’s versions of some of its other medicines, but it was its first product aimed solely at children. The company was working on a children’s version of its intravenous Maxigesic pain relief, which has been approved in 21 countries. LAWRENCE SMITH/STUFF Children’s medicines are quite challenging to develop, says Hartley Atkinson, CEO of AFT Pharmaceuticals.

Source: Stuff July 14, 2021 16:52 UTC